US-based BioMed Realty Trust is to buy MEPC’s Granta Park in Cambridge for around £127m (€157.5m).
The 472,200 sq ft (43,868 m2) asset includes 11 buildings that are home to biotechnology and pharmaceutical companies such as MedImmune, PPD Global, UCB
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.
